2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1053416461 MD
Verify on CMS →

PING WANG, MD

Endocrinology, Diabetes & Metabolism Physician in NEWPORT BEACH, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 100 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.1275/100
▲ 16 pts above national avg 83.1 · [object Object]

What the federal data shows

PING WANG, MD reported a CMS MIPS final score of 99.1275/100 — above the 83.1 national average — and filed 1,013 Medicare Part D claims in 2023.

99.1275/100
MIPS score · +16 vs avg
1K
Part D claims, 2023
48%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PING WANG, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

PING WANG, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PING WANG, MD?

High performer (top quartile)

NPI registry status

Active

Issued 09/13/2006

NPI 1053416461

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,013 62% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

99.1275/100 16.027500000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Medicare quality performance — MIPS

PING WANG, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
99.1275/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 99.1275/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 99.1275/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PING WANG, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 1601 AVOCADO AVE, NEWPORT BEACH, CA, 92660, with a listed phone of (949) 763-2204. NPI 1053416461 was issued on 09/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WANG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,013 prescription claims written by this provider, covering 100 Medicare beneficiaries and totaling roughly $665K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.1275/100 for the 2023 performance year (Quality 85.2396), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1601 AVOCADO AVE
NEWPORT BEACH, CA 92660

Provider Details

NPI 1053416461
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 09/13/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.1275
Final Score
Avg: 83.1
85.2396
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where PING WANG, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CITY OF HOPE MEDICAL FOUNDATION
NEWPORT BEACH, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to PING WANG, MD. To verify PING WANG, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

PING WANG, MD — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 1,013 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,013
Total Claims
$665K
Total Drug Cost
100
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,505
Total Day Supply
74,373
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$607K
Generic Drug Cost
$26K

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
1.51
Gender Split
52% female / 48% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PING WANG, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
104
Jardiance
Empagliflozin
70
Ozempic
Semaglutide
59
Tresiba Flextouch U-200
Insulin Degludec
54
Metformin Hcl
48
Rosuvastatin Calcium
38
Humalog Kwikpen U-100
Insulin Lispro
37
Mounjaro
Tirzepatide
31
Atorvastatin Calcium
27
Tresiba Flextouch U-100
Insulin Degludec
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How PING WANG, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

PING WANG, MD's 1,013 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as WANG.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PING WANG, MD's specialty?
PING WANG, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in NEWPORT BEACH, California. Credentials: MD.
How much does PING WANG, MD prescribe under Medicare Part D?
In 2023, PING WANG, MD wrote 1,013 Medicare Part D claims totaling $665K in drug costs for 100 beneficiaries.
What is PING WANG, MD's Medicare quality score?
PING WANG, MD has a CMS MIPS Final Score of 99.1275/100 (Quality: 85.2396). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is PING WANG, MD located?
PING WANG, MD is located at 1601 AVOCADO AVE, NEWPORT BEACH, CA, 92660. Phone: (949) 763-2204.
What is PING WANG, MD's NPI number?
PING WANG, MD's National Provider Identifier (NPI) is 1053416461, issued on 09/13/2006.
Does PING WANG, MD prescribe more brand-name or generic drugs?
PING WANG, MD's prescribing is 52% brand-name and 48% generic drugs by claim count, with $607K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does PING WANG, MD prescribe most often?
Based on 2023 Medicare Part D data, PING WANG, MD's most frequently prescribed drugs include Levothyroxine Sodium, Jardiance, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PING WANG, MD accept Medicare?
PING WANG, MD appears in CMS Medicare data with 1,013 Part D claims and 100 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PING WANG, MD's credentials?
PING WANG, MD's NPI is 1053416461 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology